Two Arivin researchers at a screen in the laboratory

Company

News

Funding rounds, accreditation, research milestones and the people behind them.

01 January 2026 Arivin selected for Deep Tech Accelerator funding by Business Finland We are very happy to be selected as one of the young and innovative companies awarded funding through the Deep Tech Accelerator (DTA) programme by Business Finland. 02 August 2025 Arivin secures €3 million seed funding to advance Future-Proof antimicrobial therapies Media release, Helsinki, Finland. The investment will accelerate research and platform technology, expand laboratory capabilities and strengthen the team. 03 August 2025 Meet the team – spotlight Patrick Hämelin Patrick Hämelin, Chief Business Officer, on moving from one of Finland’s largest corporations to an early-stage startup. 04 July 2025 Meet the team – spotlight Saima Kivimäki Saima Kivimäki, microbiology researcher, on being the first new hire and on working with highly resistant pathogens. 05 April 2023 A new treatment for multidrug-resistant bacteria published in Nature Communications A novel dual-acting anti-virulence strategy that shuts down bacterial toxins and biofilms, and evades antibiotic resistance mechanisms.